Romidepsin is effective and well tolerated in older patients with peripheral T-cell lymphoma: analysis of two phase II trials.
about
Romidepsin is effective and well tolerated in older patients with peripheral T-cell lymphoma: analysis of two phase II trials.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Romidepsin is effective and we ...... alysis of two phase II trials.
@en
type
label
Romidepsin is effective and we ...... alysis of two phase II trials.
@en
prefLabel
Romidepsin is effective and we ...... alysis of two phase II trials.
@en
P2093
P2860
P1433
P1476
Romidepsin is effective and we ...... alysis of two phase II trials.
@en
P2093
Andrei Shustov
Barbara Balser
Barbara Pro
Bertrand Coiffier
H Miles Prince
Julie Wolfson
Leslie Popplewell
Lubomir Sokol
Richard Piekarz
Robin Eisch
P2860
P304
P356
10.1080/10428194.2017.1295143
P50
P577
2017-03-07T00:00:00Z